Establishment of feline intestinal epithelial cell cultures for the propagation and study of feline enteric coronaviruses
© Desmarets et al.; licensee BioMed Central Ltd. 2013
Received: 27 February 2013
Accepted: 9 August 2013
Published: 21 August 2013
Feline infectious peritonitis (FIP) is the most feared infectious cause of death in cats, induced by feline infectious peritonitis virus (FIPV). This coronavirus is a virulent mutant of the harmless, ubiquitous feline enteric coronavirus (FECV). To date, feline coronavirus (FCoV) research has been hampered by the lack of susceptible cell lines for the propagation of serotype I FCoVs. In this study, long-term feline intestinal epithelial cell cultures were established from primary ileocytes and colonocytes by simian virus 40 (SV40) T-antigen- and human Telomerase Reverse Transcriptase (hTERT)-induced immortalization. Subsequently, these cultures were evaluated for their usability in FCoV research. Firstly, the replication capacity of the serotype II strains WSU 79–1683 and WSU 79–1146 was studied in the continuous cultures as was done for the primary cultures. In accordance with the results obtained in primary cultures, FCoV WSU 79–1683 still replicated significantly more efficient compared to FCoV WSU 79–1146 in both continuous cultures. In addition, the cultures were inoculated with faecal suspensions from healthy cats and with faecal or tissue suspensions from FIP cats. The cultures were susceptible to infection with different serotype I enteric strains and two of these strains were further propagated. No infection was seen in cultures inoculated with FIPV tissue homogenates. In conclusion, a new reliable model for FCoV investigation and growth of enteric field strains was established. In contrast to FIPV strains, FECVs showed a clear tropism for intestinal epithelial cells, giving an explanation for the observation that FECV is the main pathotype circulating among cats.
Feline coronaviruses (FCoVs) are associated with both enteric and systemic diseases in domestic and wild Felidae. The feline enteric coronavirus (FECV) is an ubiquitous enteropathogenic virus, replicating in epithelial cells of both small and large intestine after oral uptake [1–5]. The mild enteritis caused by this replication is usually unapparent or is manifested by a transient diarrhoea in young kittens . Around 13% of all infected cats are not able to clear the virus . In these cats, the virus persists for several months or even years in the epithelium of the large intestine [2–5, 7]. Since FECVs are easily transmitted from cat to cat by faecal-oral route, they are enzootic among most cat populations [3, 8]. Although FECV-infections manifest subclinically, they may be the start of a lethal outcome. During replication, mutations can occur in the viral genome, providing the virus with tools to productively replicate in monocytes/macrophages [9–12]. This mutational variant, designated feline infectious peritonitis virus (FIPV), causes a chronic and highly fatal systemic disease, FIP, characterized by a diffuse pyogranulomatous (peri)phlebitis and serositis in presence (wet form) or absence (dry form) of fibrinous exudate in the affected body cavities [13–15]. In contrast to FECV which is highly infectious but seldom causes disease, FIPV shows a low infectivity but high mortality (95-100%) . Losses from FIP are typically unpredictable and occur in only a restricted fraction (< 10%) of all seropositive cats [6, 16–18]. However, the lack of tools to successfully prevent and control the disease has an enormous financial, emotional and ethical impact, and makes FIP the most feared infectious cause of death in cats . To date, it remains unknown why FECV and FIPV show such a clinically (mild enteritis versus FIP) and epidemiologically (easy versus restricted transmission) different behaviour.
Besides the two pathotypes, FCoVs also occur as two serotypes . Worldwide, the majority of all strains (both FECVs and FIPVs) are serotype I viruses [21–26]. In contrast to the type I viruses that are 100% feline, type II viruses possess spike and adjacent genes of canine origin since they have arisen by double recombination events between type I FCoVs and canine coronavirus (CCV) [27, 28]. Despite their lower prevalence, most comparative in vitro studies have been performed with the easily cell culture growing serotype II strains WSU 79–1683 and WSU 79–1146 [9, 10, 12, 29]. FCoV WSU 79–1146 has been shown to be a highly virulent, readily FIP-inducing virus due to its efficient infection of monocytes/macrophages. FCoV WSU 79–1683, on the other hand, is an avirulent virus, inducing at most a mild enteritis in kittens. The poor systemic dissemination of this virus has been attributed to a restricted, inefficient infection of monocytes/macrophages [9, 10, 12, 30]. To date, cell culture propagation of the abundantly present serotype I FECVs has never been achieved and only few serotype I FIPV strains have been adapted to grow in felis catus whole fetus (fcwf) cells. However, most of these strains have lost their pathogenicity through cell culture adaptation [17, 31]. Hence, comparative studies between non-culture adapted FECVs and FIPV have only been possible by comparing genomes of both naturally occurring strains [18, 32–35]. To date, it remains unclear which genetic determinants make up a certain pathotype.
In the present study, cultures of intestinal epithelial cells from the ileum (ileocytes) and colon (colonocytes) were established by inducing a combined expression of SV40 T-antigen and hTERT in primary ileocytes and colonocytes. The reliability of these cultures for their use in FCoV-research was first investigated by comparing replication capacities of the, at high titre available, avirulent FCoV WSU 79–1683 and the highly virulent FCoV WSU 79–1146 with results obtained for the primary cultures. Since those serotype II strains have been heavily cell culture adapted, the usability of the intestinal epithelial cell cultures in FCoV research was further evaluated by investigating their susceptibility for different field strains, present in faeces and tissues of coronavirus-infected cats.
Materials and methods
Since cats are euthanized every day in practice, tissues of these animals can be used in research in order to reduce the number of laboratory cats. Therefore, the intestines of euthanized conventional cats were used in this study and were a kind contribution to research by the owners. This study was approved by the Local Ethical and Animal Welfare Committee of the Faculty of Veterinary Medicine of Ghent University (EC2012/043) and informed consent was obtained from all owners. Faecal extracts from SPF cats (Harlan laboratories, Indianapolis, IN, USA) experimentally infected with FECV UCD were used as a source of this enteric field strain. These infection experiments were approved by the Local Ethical and Animal Welfare Committee of the Faculty of Veterinary Medicine of Ghent University (EC2012/042).
Isolation and cultivation of primary ileocytes and colonocytes
Cats were sedated by intramuscular injection of a mixture of Ketamin (0.05 mL/kg; Anesketin®, Eurovet, Heusden-Zolder, Belgium) and Midazolam (0.05 mL/kg; Dormicum®, Roche, Brussels, Belgium). Subsequently, the cats were euthanized by intracardial injection of 20% SodiumPentobarbital (1 mL/1.5 kg; Kela Laboratories, Hoogstraten, Belgium). The protocol used for the isolation of primary ileocytes and colonocytes was based on the one described by Rusu et al., with minor adaptations . Directly after euthanasia, the ileum and colon were aseptically removed and transported in ice-cold Dulbecco’s Modified Eagle Medium (DMEM; Gibco BRL, Merelbeke, Belgium) supplemented with 100 U/mL penicillin (Continental Pharma Inc., Puurs, Belgium), 0.1 mg/mL streptomycin (Certa, Braine l’Alleud, Belgium), 0.1 mg/mL gentamycine (Gibco BRL) and 10% foetal bovine serum (FBS; Gibco BRL). Subsequently, the pieces of intestine were inverted, i.e. mucosal side facing outwards, and the intestinal content was removed by three vigorous washings in ice-cold DMEM supplemented with antibiotics. The intestinal mucosa was digested in DMEM containing collagenase I (0.4 mg/mL, Invitrogen, Paisley, UK) and dispase (1.2 mg/mL, Sigma, St. Louis, MO, USA) for 15 min (ileum) or 20 min (colon) at 37 °C. Then, the digestion medium was refreshed and the pieces were incubated for another 45 min (ileum) or 60 min (colon) at 37 °C. Subsequently, the pieces were longitudinally opened and the digested mucosa was scraped with a sterile scalpel blade. The scrapings were incubated in warm DMEM supplemented with antibiotics and dispase (1.2 mg/mL) for 10 min whilst pipetting. After centrifugation (140 × g, 3 min) the pellet was resuspended in DMEM containing 2% D-Sorbitol (Sigma) and 10% FBS, and centrifuged (50 × g, 3 min) in order to separate as much single cells (most probably contaminating stromal cells) as possible from the epithelial cell clusters. This sorbitol centrifugation was repeated 5 times. The resulting pellet was subsequently resuspended 1:3 (vol:vol) in culture medium consisting of DMEM/F-12 supplemented with 100 U/mL penicillin, 0.1 mg/mL streptomycin and 0.1 mg/mL gentamycin, 10% FBS (Gibco BRL), 10 ng/mL epidermal growth factor (Sigma), 1% insulin-transferrin-selenuim-X (Invitrogen), 100 nM hydrocortisone (Sigma), 1% non-essential amino acids 100× (Gibco BRL), and 1 μg/mL 3,3’ ,5-Triiodo-L-thyronine sodium salt (Sigma). The cells were seeded in 24-well plates or on glass coverslips coated with collagen type I (Roche Diagnostics, Vilvoorde, Belgium). The cells were cultivated in a 37 °C / 5% CO2 atmosphere. After 24 h, the culture medium was replaced by medium containing 2% FBS to restrict the outgrowth of non-epithelial cells. Medium was changed every other day. Morphological features of the primary cultures were evaluated every day by light microscopy (Olympus).
Characterization of the primary cultures
To assess the origin of the primary cells, double-immunostainings were performed against pancytokeratin and vimentin. Therefore, the cells were fixed with 4% paraformaldehyde in PBS for 10 min at room temperature (RT) followed by permeabilization with 0.1% Triton X-100 for 2 min at RT. The cells were incubated with monoclonal anti-cytokeratin antibodies (Dako Denmark A/S) containing 10% normal goat serum for 1 h at 37 °C, followed by goat anti-mouse-Texas Red labelled antibodies for 1 h at 37 °C (Molecular Probes, Eugene, Oregon, USA). Afterwards, the cells were incubated for 45 min at 37 °C with monoclonal anti-vimentin antibodies (Lab Vision Corporation, Fremont, CA, USA) labelled with Zenon® Alexa Fluor 488 (Invitrogen) according to the manufacturer’s protocol. Nuclei were stained with Hoechst 33342 (Molecular Probes) for 10 min at RT. The slides were mounted using glycerine-PBS solution (0.9:0.1, vol:vol) with 2.5% 1,4-diazabicyclo[2.2.2]octane (Janssen Chimica, Beerse, Belgium) and analysed by fluorescence microscopy (DM B fluorescence microscope, Leica Microsystems GmbH, Heidelberg, Germany).
Immortalization of primary feline ileocytes and colonocytes
At 4 days post isolation, primary cultures of ileocytes and colonocytes from the same cat were transduced with both recombinant lentiviruses expressing either the SV40 large T antigen or the hTERT protein (Applied Biological Materials Inc., Canada) in addition of polybrene (8 μg/mL, Applied Biological Materials Inc.). After 30 min, medium was added and the cells were further incubated with the virus (1:1 vol:vol in medium) overnight. The following day, the viral supernatant was removed and cells were further incubated in medium. After 5 days, the cells were detached by trypsinization with 0.25% trypsin - 0.02% EDTA, subcultured in collagen-coated wells (split ratio 1:2) and evaluated daily for clonal expansion by light microscopy (Olympus). Clusters of cells with epithelial (cobblestone-like) morphology were marked and other cells in the well were removed by scraping. Subsequently, the epithelial clusters were detached by trypsinization and further expanded in collagen-coated flasks to generate a long-term culture of both small and large intestinal epithelial cells.
Characterization of the ileocyte and colonocyte cell lines
To confirm the epithelial character of both cell lines, double-immunostainings were performed against cytokeratin and vimentin as described above. The success of transduction was assessed by performing immunocytochemical stainings against the SV 40 large T antigen and hTERT. Therefore, cells seeded on collagen-coated glass coverslips were fixed with 4% paraformaldehyde, followed by permeabilization with 0.1% Triton X-100. The cells were incubated with polyclonal rabbit antibodies against hTERT (Applied Biological Materials Inc.) containing 10% normal goat serum for 1 h at 37 °C, followed by goat ant-rabbit-FITC labelled antibodies (Molecular Probes) for 1 h at 37 °C. Subsequently, the cells were incubated with monoclonal antibodies against the SV40 large T antigen (Applied Biological Materials Inc.) containing 10% normal goat serum, followed by goat anti-mouse-AF594 labelled antibodies (Molecular Probes), each for 1 h at 37 °C. Nuclei were stained and slides were mounted as described above. The cells were analysed by fluorescence microscopy (DM B fluorescence microscope, Leica Microsystems GmbH). In addition, immunocytochemical stainings against the intestinal brush border hydrolase aminopeptidase N were performed. Therefore, cells were fixed with 1% paraformaldehyde and incubated with the monoclonal antibody R-G-4 (kindly provided by Dr Hohdatsu, Department of Veterinary Infectious Diseases, Towada, Japan) containing 10% normal goat serum followed by goat anti-mouse-FITC labelled antibodies (Molecular Probes), each for 1 h at 37 °C. Images were obtained using a Leica TCS SPE laser scanning spectral confocal system linked to a DM B fluorescence microscope (Leica Microsystems). Argon and He/Ne lasers were used for exciting FITC and Texas Red fluorochromes, respectively. Leica confocal software was used for image acquisition.
Expression kinetics of viral antigens in FCoV WSU 79–1683 and FCoV 79–1146 infected cells
A third passage of the FCoV strains 79–1683 and 79–1146 grown in Crandell feline kidney (CrFK) cells were used. FCoV WSU 79–1683 was obtained from the American Type Culture Collection (ATCC) and FCoV WSU 79–1146 was kindly provided by Dr Egberink (Department of Infectious Diseases and Immunology, Utrecht University, the Netherlands). At 4 days post isolation, primary cells of three cats were inoculated at a multiplicity of infection (moi) of 1. After 1 h incubation (37 °C, 5% CO2) the cells were washed 3 times with warm DMEM and further incubated in medium. Monolayers of continuous ileocyte and colonocyte cultures were inoculated in the same way. At different time points (0, 3, 6, 9, 12 and 24 h) post inoculation, cells were fixed with 4% paraformaldehyde for 10 min and permeabilized with 0.1% Triton X-100 for 2 min at RT. For the primary cultures, double-immunostainings against both FCoV-antigens and cytokeratin were performed to visualize the infected epithelial cells. For the continuous cultures, only viral antigens were stained. Viral antigens were visualized with polyclonal FITC-labelled anti-FCoV antibodies (VMRD, Pullman, USA). Cytokeratin-positive cells were visualized as described above. Nuclei were stained with Hoechst, the slides were mounted and analysed by fluorescence microscopy (Leica Microsystems GmbH). All experiments were performed 3 times. The area under the curve was determined for each experiment. Triplicate assays were compared using a Mann–Whitney U test. Statistical analysis was performed using GraphPad Prism version 5.0c (GraphPad software, San Diego, CA, USA). P values ≤ 0.05 were considered significantly different.
Using primary cells of conventional cats holds the risk that cultured cells are already infected with FCoVs. Therefore, mock-infected cells were accurately screened to exclude the presence of inherent infected cells. All cells were negative for inherent coronavirus.
One-step real time RT-PCR for the detection of the viral load in field strain suspensions
RNA was extracted from the faecal suspensions using the QIAamp Viral RNA Mini Kit (Qiagen, Benelux BV, Belgium) and from tissue suspensions with the RNeasy Mini Kit (Qiagen). To avoid detection of subgenomic mRNA’s, primers were designed using the Primer 3 plus software within a conserved region of ORF1b based on FCoV sequences available in GenBank. A 20 μL PCR mixture was used per reaction and contained 10 μL Precision OneStep™ qRT-PCR Mastermix with SYBR Green and ROX (PrimerDesign, Southampton, UK), 0.2 μM forward primer ORF1bFW (5’-TGGACCATGAGCAAGTCTGTT-3’), 0.4 μM reverse primer ORF1bRV (5’-CAGATCCATCATTGTGTACTTTGTAAGA-3’) and 3 μL RNA or diluted standard RNA (see below). A reverse transcription step of 10 min at 55 °C and an enzyme activation step at 95 °C for 8 min were followed by 40 cycles, each 10 s at 95 °C and 60 s at 58 °C. A first-derivative melting curve analysis was performed by heating the mixture to 95 °C for 15 s, then cooling to 60 °C for 1 min, and heating back to 95 °C at 0.3 °C increments. Reverse transcription, amplification, monitoring, and melting curve analysis were carried out in a Step One Plus™ real-time PCR system (Applied Biosystems, Life Technologies Corporation, Carlsbad, CA, USA).
Synthetic RNA standards for absolute quantitation
RNA was extracted from faecal suspensions containing FECV UCD using the QIAamp Viral RNA Mini Kit (Qiagen). The RNA was reverse-transcribed into cDNA using the SuperScript™ III First-Strand Synthesis System for RT-PCR (Invitrogen). Briefly, 250 ng RNA was incubated for 5 min at 65 °C with 2 μM reverse primer ORF1bRV and 10 mM dNTP mix. Afterwards, an equal volume of cDNA synthesis mix, containing 10× RT buffer, 25 mM MgCl2, 0.1 M DTT, 40 U/μl RNase OUT and 200 U/μL Superscript III RT was added and incubated for 50 min at 50 °C. The reaction was terminated at 85 °C for 5 min. RNA was removed by incubation with RNase H for 20 min at 37 °C. The 50 μL PCR mixture for the amplification of the cDNA contained 10 μL 5× Herculase II reaction buffer, 0.8 μL dNTP mix, 2 μL DNA template, 0.25 μM forward primer ORF1bFW modified with a T7 promoter sequence at its 5’ end (5’- TAATACGACTCACTATAGGG TGGACCATGAGCAAGTCTGTT-3’), 0.25 μM reverse primer ORF1bRV, and 1 μL Herculase II fusion DNA polymerase (Agilent Technologies Inc., Santa Clara, CA, USA). After a denaturation step for 1 min at 95 °C, 30 cycles of amplification, each 20 s at 95 °C, 20 s at 50 °C, and 60 s at 68 °C, were followed by a terminal elongation of 4 min at 68 °C. Fragment length was controlled by agarose gel electrophoresis and fragments with the correct length were excised and purified from the gel using the Nucleospin® Gel and PCR Clean-up kit (Macherey-Nagel, Düren, Germany). cRNA standards were transcribed by incubation for 1 h at 37 °C with 10× transcription buffer, 500 μM rNTPs and 20 U T7 RNA polymerase-Plus Enzyme Mix (Applied Biosystems). Transcription reactions were DNase I treated and the amount of RNA was determined using the Nanodrop 2000 system. Ten-fold serial dilutions of the RNA were made over a range of 6 log units (107-102) for the generation of the standard curve (Efficiency: 93.96 ± 0.76%; R2: 0.999).
Assessment of the infectious coronavirus titre in faecal and tissue suspensions
Faecal samples were collected from healthy cats housed in 3 different catteries / multi-cat environments that have dealt with FIP in the past. Faecal extracts of experimentally infected cats containing an unknown titre of FECV strain UCD (originally isolated at UC Davis, ) were a kind gift of Dr Rottier (Department of Infectious Diseases and Immunology, Utrecht University, the Netherlands). This suspension was clarified by centrifugation at 4000 × g for 10 min and SPF cats were infected with the supernatant. Faecal extracts from one cat were used as a source of this enteric field strain. From all faecal samples, 20% suspensions were made in DMEM supplemented with 2% FBS (Gibco, BRL), 100 U/mL penicillin (Continental Pharma Inc.), 0.1 mg/mL streptomycin (Certa), and 0.1 mg/mL gentamycin (Gibco BRL). From 4 cats with FIP (immunohistochemically confirmed), faeces and affected tissues were collected. From tissue homogenates, 20% suspensions were made in DMEM supplemented with 100 U/mL penicillin (Continental Pharma Inc.), 0.1 mg/mL streptomycin (Certa), and 0.1 mg/mL gentamycin (Gibco BRL). Suspensions were centrifuged (1200 × g, 4 °C, 20 min), and the supernatant was aliquoted and stored at −70 °C until use. All samples were initially screened by immunofluorescence in both cell lines by inoculating monolayers, seeded on collagen coated coverslips, with 250 μL of the suspensions for 1 h at 37 °C. Thereafter, cells were washed and further incubated in medium for 24 h. After fixation and permeablization, infected cells were visualized as described above. In addition, the amount of infectious virus was quantified in all samples, including the initially negative ones. Therefore, monolayers of colonocytes, seeded in collagen I coated 96-well plates, were inoculated with 50 μL of serially diluted (1/10) faecal or tissue suspensions (ranging from 100 to 10-7). After 1 h (37 °C, 5% CO2), medium was added and the cells were further incubated for 72 h. To reduce cell loss due to toxicity, undiluted suspensions were removed from the wells 1 h post inoculation (pi), the cells were washed 2 times and further incubated in medium for 72 h. Then, plates were washed with PBS, air-dried (1 h, 37 °C) and frozen (−20 °C). The 50% tissue culture infectious dose (TCID50) was determined by means of immunoperoxidase monolayer assay (IPMA). Therefore, cells were fixed and permeabilized by incubation with PF 4% (10 min, RT), followed by incubation with methanol containing 1% H2O2 (5 min, RT). Then, cells were incubated with PBS containing 10% normal goat serum and 0.1% Tween 80 for 30 min at 37 °C. Subsequently, cells were incubated with monoclonal antibodies against the N-protein (produced and characterized in the laboratory of the authors), followed by incubation with goat anti-mouse HRP-labelled antibodies. Infected cells were visualized by adding sodium-acetate buffer containing amino-ethylcarbazola (AEC) and H2O2 for 10 min at RT. The fifty percent end-point was calculated according to the method of Reed and Muench . The serotype of all samples was determined by means of RT-PCR described by Addie et al. .
Determination of infectious virus in FIPV-suspensions by inoculation of monocyte-derived macrophages
Feline monocytes were isolated and seeded on glass coverslips as previously described . At 7 days post seeding, cells were inoculated with 250 μL of the suspensions. After 1 h at 37 °C, cells were washed and further incubated in medium for 24 h. After fixation and permeabilization, infected cells were visualized by immunofluorescence staining as described above.
Propagation and titration of FECV UCD and UG-FH8
Two different faecal strains, UCD and UG-FH8, were passaged 3 times in continuous colonocyte cultures, starting from the faecal suspensions. After 3 passages, the TCID50 was determined as described above. In addition, sequencing of ORF3 and ORF7 was performed to check for their integrity. Therefore, primers were designed using published sequences of FCoV ORF3 and ORF7 in GenBank. Viral RNA was extracted from the faecal suspensions with the QIAamp Viral RNA Mini Kit (Qiagen) and cDNA was generated using SuperScript™ III First-Strand Synthesis System for RT-PCR (Invitrogen). Amplification was carried out in a 50 μL reaction using Herculase II fusion DNA polymerase (Agilent Technologies Inc., Santa Clara, CA, USA). The Nucleospin® Gel and PCR Clean-up kit (Macherey-Nagel) was used for purification of the PCR products. Sequencing was performed by the GATC Biotech Company (Konstanz, Germany). Additionally, it was investigated if both third passage strains still showed a specific enterotropism by inoculating other feline cell lines (CrFK and fcwf cells). 24 h pi, infected cells were visualized by immunofluorescence staining as described above.
Morphological features and characterization of the primary cultures
Immunofluorescence stainings against cytokeratin (intermediate filaments typically found in the cytoskeleton of epithelial cells) and vimentin (intermediate filaments expressed by mesenchymal cells) confirmed the epithelial nature of the polygonal, cobblestone-like cells (Figure 1C, 1F). At 4 days post isolation, the majority of the cells (> 90%) in the colon cultures was still of epithelial origin. For the ileum cultures, the vimentin positive mesenchymal cells had expanded in between the epithelial clusters, occupying around 50% of the wells. Remarkably, some of the ileum epithelial cells did also express vimentin, resembling dedifferentiated epithelial cells typically found after injury or in tumours (Figure 1C).
Expression kinetics of viral antigens in FCoV WSU 79–1683 and WSU 79-1146-infected primary ileocytes and colonocytes
Morphological features and characterization of the established continuous ileocyte and colonocyte cultures
Antigen expression kinetics of FCoV WSU 79–1683 and WSU 79–1146 in continuous ileocyte and colonocyte cultures
Titration of field strains in faecal and tissue suspensions
QPCR- and infectious titre of different faecal and tissue suspensions from healthy and FIP cats
QPCR titre (Log10copies / g)
Infectious titre (Log10TCID50/ g)
Faeces healthy cats
Faeces healthy cats
Faeces healthy cats
Faeces healthy cats
Faeces healthy cats
Faeces healthy cat
Faeces healthy cat
Faeces healthy cat
Faeces healthy cats
Faeces healthy cat
Faeces healthy cats
Faeces healthy cats
Faeces healthy cats
Faeces healthy cats
Faeces healthy cat
Faeces healthy cats
Faeces healthy cat 6d pi
Faeces FIP cat 1
Faeces FIP cat 2
Faeces FIP cat 3
Faeces FIP cat 4
Kidney FIP cat 1
Omentum FIP cat 2
Spleen FIP cat 3
Omentum FIP cat 4
Propagation and titration of FECV UCD and UG-FH8
Infectious titre and status of ORF3 and ORF7 in cell culture propagated viruses
Infectious titre (Log10TCID50/ mL)
Status ORF3 at P3
Status ORF7 at P3
In this study, immortalized cultures of both small (ileum) and large (colon) intestinal epithelial cells were established and validated for their use in feline coronavirus research. Intestinal epithelial cells are important target cells in FCoV pathogenesis but to date such cell lines are not available. The establishment of primary intestinal epithelial cell cultures has been proven to be difficult because of the induction of programmed cell death after disruption from the extracellular matrix, the uncontrolled contamination with stromal cells and the still unknown homeostatic components needed for the maintenance of these cultures . To avoid induction of apoptotic signals by disrupting cell-matrix adhesions, a combination of collagenase and dispase was used in this study to digest the mucosa, allowing the isolation of epithelial cell clusters. These were subsequently separated as much as possible from the contaminating single stromal cells by D-sorbitol density centrifugation. The primary colon cultures showed a relative high purity of epithelial cells, whereas primary ileum cultures were much more contaminated with stromal cells. The contamination with mesenchymal cells is intrinsic to the isolation method used and therefore inevitable. Yet, the epithelial cells could be cultured for a week without overgrowth by these cells, making both primary cultures ideal models for studying interactions with enterotropic infectious agents. Remarkably, some primary cells co-expressed cytokeratin and vimentin filaments, which is often found in injured epithelial cells, tumours and in primary cultures due to the detachment of the cells from their natural environment during isolation. In these cells, the epithelial differentiation is turned back to a more embryonic state, amongst others characterized by de novo expression of vimentin filaments . Only a minority of the cells did express vimentin, suggesting that most cells were able to restore their differentiation with the used culture conditions.
Although the doubtful origin and clear signs of cell culture adaptation [17, 40], FCoV WSU 79–1683 and FCoV WSU 79–1146 were the only available strains representing an avirulent and related virulent strain at that time of the study. Hence, those strains were initially used for investigating the susceptibility of primary enterocytes to both virulent and avirulent FCoVs. Replication of both strains have been studied in CrFK cells, fcwf cells, peritoneal macrophages, bone marrow-derived macrophages and peripheral blood monocytes [9, 10, 12, 29]. In contrast to the available continuous cultures (CrFK and fcwf cells), the difference in virulence between both strains was reflected in vitro when using primary FIPV target cells (monocytes/macrophages). The highly efficient and mostly sustained infection of FIPV in macrophages and monocytes from susceptible cats, in contrast to an inefficient and not sustained infection of the avirulent WSU 79–1683 in those cells, may explain why FIPV behaves as a harmful invasive virus causing this progressive systemic disease [9, 10, 12]. As was previously shown for monocytes/macrophages, the present study confirms that both strains exhibit clear differences in cell tropism. In contrast to FCoV WSU 79–1146, the avirulent WSU 79–1683 efficiently infected and replicated in intestinal epithelial cells, resulting in exactly opposing kinetics as were found for macrophages .
Primary cultures are ideal tools to reliably investigate virus-host interactions. Nevertheless, isolation of primary epithelial cells is labour-intensive, the cultures are often contaminated with a various amount of mesenchymal cells and the yield is variable and rather low. To activate research with those cells, long-term cultures were derived from both primary ileocytes and colonocytes by SV40 T-antigen- and hTERT-induced immortalization, resulting in the generation of two feline intestinal epithelial cell cultures. The epithelial nature of both cell lines was confirmed by their cobblestone morphology, dome formation and cytokeratin expression. These newly established cell lines could be valuable tools for virus research. However, immortalized cell lines are often phenotypically transformed, making reliable research with these cells questionable. In the present study it was shown that, in contrast to the primary cultures, the majority of the cells co-expressed cytokeratin and vimentin filaments, suggesting that the cultures were less differentiated compared to their primary counterparts. Therefore, the reliability of the established cell lines for their use in feline coronavirus research was further investigated and confirmed. Antigen expression kinetics of FCoV WSU 79–1683 and FCoV WSU 79–1146 were comparable with the results obtained with the primary cultures, showing a significant difference in cell tropism between both strains. As mentioned before, comparative studies in the available continuous feline cell lines (CrFK and Fcwf cells) showed no replicative differences between both serotype II strains [9, 10, 29]. However, both cultures are hardly sensitive to serotype I FCoVs. To date, cultivation of serotype I FECVs has never been achieved and only few serotype I FIPV strains could be adapted to grow in continuous cell cultures. In addition, most of these strains seem to have lost their pathogenicity through cell culture adaptation [17, 31]. In the present study, the newly established intestinal epithelial cell cultures were further evaluated for their susceptibility to serotype I field strains. Infectious, enterotropic virus was found in 57% (8/14) of all FCoV-positive faecal samples originating from healthy cats in 3 geographically distinct multi-cat environments. One of those samples was detected only by immunofluorescence staining. This higher sensitivity can be explained by the use of more inoculum in that test. In the majority of the positive samples, infectious titres were always between 103.05 to 105.77 times lower compared to the total virus titre. This difference can be attributed to the presence of defective particles, but infectious titres in such faecal samples can possibly be underestimated due to faecal toxicity to the cells and the presence of neutralizing IgA antibodies as well. In infection experiments with FECV UCD, the amount of infectious particles was typically 3–4 log10 times lower compared to the total amount of particles in the first week pi, but this further increased thereafter most probably due to the generation of neutralizing antibodies (data not shown). It is impossible to estimate when cats in multi-cat environments became infected and the presence of neutralizing antibodies can explain why infectious virus in some of the faecal samples with a quite high viral load was not detectable. Coronavirus was detected in 3/4 of the tested faecal samples from FIP cats. Previously, it has been shown that faecal viruses from FIP cats did not cause enteric infections or FIP upon inoculation of laboratory cats . This can explain why, despite its high viral load, no infectious virus (neither in enterocytes nor in monocytes/macrophages) was found in the faeces of FIP cat 1 (UG-FF1). However, enterotropic virus was found in the faeces from another FIP cat (UG-FF2) that was housed in a Belgian shelter. To search for explanations for this discrepancy, accessory proteins of the virus in faecal and tissue suspensions of that cat were sequenced (data not shown). As in all faecally shed FCoVs sequenced so far [18, 32, 35], the faecal strain carried an intact 3c gene. In addition, this strain showed only 96% and 89% homology with the tissue strain based on 7a and 7b protein respectively. So it seems that this cat was co-infected with another, most probably enteric strain circulating in that shelter, explaining the shedding of enterotropic infectious virus in that cat. In 3/4 of the tissue samples from FIP cats (UG-TF5, UG-TF9 and UG-TF17), infectious virus was found by inoculation of monocyte-derived macrophages. However, these viruses seemed to have lost their tropism for intestinal epithelial cells since no infection was detected after inoculation of the intestinal epithelial cell cultures. The fact that FECV is the only pathotype that is well adapted for growth in intestinal epithelial cells shows that FECVs have the advantage over FIPVs to spread amongst cats. These findings are in agreement with previous observations on FCoV epidemiology, explaining the restricted transmission of FIPVs and hence low incidence of cats with FIP [6, 16–18].
Since no cell culture-propagated serotype I enteric strains are available, two of those strains, FECV UCD and UG-FH8, were further propagated in the established cultures. After 3 passages, both virus strains were raised in titre with 3 log10 TCID50 / mL, making them usable for further in vitro experiments. It has been described that the 7b glycoprotein is not necessary for replication in cell cultures and hence this gene is readily lost by in vitro propagation. Therefore, alterations in the 7b protein can be a sign for cell culture adaptation as seen in many of the cell culture propagated serotype I FIPVs . In present study, no such signs of cell culture adaptation were detected for both 3th passage strains, which still carried intact ORF7 genes identical to the original faecal strains. All field enteric strains sequenced so far carried intact 3c genes [18, 32, 35]. To date, the only available avirulent, enteritis-inducing strain, WSU 79–1683, has a mutated 3c gene and for that reason doubt has been cast on the use of this strain as a typical enteric pathotype [17, 40]. Both FECV UCD and UG-FH8 propagated in this study still carried an intact (and identical to the original strain) ORF3. In addition, the cell culture propagation of both strains did not extend their tropism to other non-enterocytic feline cells, making them useful as representatives of the enteric pathotype.
In conclusion, we established cultures of both feline small and large intestinal epithelial cells, providing new and reliable in vitro models for studying enteric pathogenesis processes of FCoVs. These enterocyte cultures were susceptible to different enteric serotype I field strains, while FIPVs were clearly restricted in their replication in intestinal epithelial cells. Two of the enteric strains were further propagated, providing relevant enteric strains for future FCoV research.
We are grateful to Dr Egberink and Dr Rottier for supplying the virus strains. We also acknowledge Ytse Noppe for her excellent technical support. We gratefully thank the vets, and particularly Laurent Pauwels, for the interaction with the owners of the cats and of course the owners as well for their contribution to this work. This research was funded by The Research Foundation-Flanders (FWO-Vlaanderen; G.0284.09 N). LMBD was supported by a doctoral fellowship of The Research Foundation-Flanders. DAJO, AD, BLV and IDMR were supported by the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT Vlaanderen).
- Meli M, Kipar A, Muller C, Jenal K, Gonczi E, Borel N, Gunn-Moore D, Chalmers S, Lin F, Reinacher M, Lutz H: High viral loads despite absence of clinical and pathological findings in cats experimentally infected with feline coronavirus (FCoV) type I and in naturally FCoV-infected cats. J Feline Med Surg. 2004, 6: 69-81. 10.1016/j.jfms.2003.08.007.View ArticlePubMedGoogle Scholar
- Kipar A, Meli ML, Baptiste KE, Bowker LJ, Lutz H: Sites of feline coronavirus persistence in healthy cats. J Gen Virol. 2010, 91: 1698-1707. 10.1099/vir.0.020214-0.View ArticlePubMedGoogle Scholar
- Pedersen NC, Boyle JF, Floyd K, Fudge A, Barker J: An enteric coronavirus infection of cats and its relationship to feline infectious peritonitis. Am J Vet Res. 1981, 42: 368-377.PubMedGoogle Scholar
- Hayashi T, Watabe Y, Nakayama H, Fujiwara K: Enteritis due to feline infectious peritonitis virus. Nihon Juigaku Zasshi. 1982, 44: 97-106. 10.1292/jvms1939.44.97.View ArticlePubMedGoogle Scholar
- Herrewegh AA, Mahler M, Hedrich HJ, Haagmans BL, Egberink HF, Horzinek MC, Rottier PJ, de-Groot RJ: Persistence and evolution of feline coronavirus in a closed cat-breeding colony. Virology. 1997, 234: 349-363. 10.1006/viro.1997.8663.View ArticlePubMedGoogle Scholar
- Addie DD, Jarrett O: Use of a reverse-transcriptase polymerase chain reaction for monitoring the shedding of feline coronavirus by healthy cats. Vet Rec. 2001, 148: 649-653. 10.1136/vr.148.21.649.View ArticlePubMedGoogle Scholar
- Stoddart ME, Gaskell RM, Harbour DA, Pearson GR: The sites of early viral replication in feline infectious peritonitis. Vet Microbiol. 1988, 18: 259-271. 10.1016/0378-1135(88)90092-2.View ArticlePubMedGoogle Scholar
- Addie DD, Jarrett O: A study of naturally occurring feline coronavirus infections in kittens. Vet Rec. 1992, 130: 133-137. 10.1136/vr.130.7.133.View ArticlePubMedGoogle Scholar
- Rottier PJ, Nakamura K, Schellen P, Volders H, Haijema BJ: Acquisition of macrophage tropism during the pathogenesis of feline infectious peritonitis is determined by mutations in the feline coronavirus spike protein. J Virol. 2005, 79: 14122-14130. 10.1128/JVI.79.22.14122-14130.2005.PubMed CentralView ArticlePubMedGoogle Scholar
- Dewerchin HL, Cornelissen E, Nauwynck HJ: Replication of feline coronaviruses in peripheral blood monocytes. Arch Virol. 2005, 150: 2483-2500. 10.1007/s00705-005-0598-6.View ArticlePubMedGoogle Scholar
- Vennema H, Poland A, Foley J, Pedersen NC: Feline infectious peritonitis viruses arise by mutation from endemic feline enteric coronaviruses. Virology. 1998, 243: 150-157. 10.1006/viro.1998.9045.View ArticlePubMedGoogle Scholar
- Stoddart CA, Scott FW: Intrinsic resistance of feline peritoneal macrophages to coronavirus infection correlates with in vivo virulence. J Virol. 1989, 63: 436-440.PubMed CentralPubMedGoogle Scholar
- Kipar A, Bellmann S, Kremendahl J, Kohler K, Reinacher M: Cellular composition, coronavirus antigen expression and production of specific antibodies in lesions in feline infectious peritonitis. Vet Immunol Immunopathol. 1998, 65: 243-257. 10.1016/S0165-2427(98)00158-5.View ArticlePubMedGoogle Scholar
- Horzinek MC, Osterhaus AD: The virology and pathogenesis of feline infectious peritonitis. Brief review. Arch Virol. 1979, 59: 1-15. 10.1007/BF01317889.View ArticlePubMedGoogle Scholar
- Montali RJ, Strandberg JD: Extraperitoneal lesions in feline infectious peritonitis. Vet Pathol. 1972, 9: 109-121. 10.1177/030098587200900204.View ArticlePubMedGoogle Scholar
- Addie DD, Toth S, Murray GD, Jarrett O: Risk of feline infectious peritonitis in cats naturally infected with feline coronavirus. Am J Vet Res. 1995, 56: 429-434.PubMedGoogle Scholar
- Pedersen NC: A review of feline infectious peritonitis virus infection: 1963–2008. J Feline Med Surg. 2009, 11: 225-258. 10.1016/j.jfms.2008.09.008.View ArticlePubMedGoogle Scholar
- Pedersen NC, Liu H, Scarlett J, Leutenegger CM, Golovko L, Kennedy H, Kamal FM: Feline infectious peritonitis: role of the feline coronavirus 3c gene in intestinal tropism and pathogenicity based upon isolates from resident and adopted shelter cats. Virus Res. 2012, 165: 17-28. 10.1016/j.virusres.2011.12.020.View ArticlePubMedGoogle Scholar
- Wolf J: The impact of feline infectious peritonitis on catteries. Feline Practice. 1995, 23: 21-23.Google Scholar
- Fiscus SA, Teramoto YA: Antigenic comparison of feline coronavirus isolates: evidence for markedly different peplomer glycoproteins. J Virol. 1987, 61: 2607-2613.PubMed CentralPubMedGoogle Scholar
- Vennema H: Genetic drift and genetic shift during feline coronavirus evolution. Vet Microbiol. 1999, 69: 139-141. 10.1016/S0378-1135(99)00102-9.View ArticlePubMedGoogle Scholar
- Addie DD, Schaap IA, Nicolson L, Jarrett O: Persistence and transmission of natural type I feline coronavirus infection. J Gen Virol. 2003, 84: 2735-2744. 10.1099/vir.0.19129-0.View ArticlePubMedGoogle Scholar
- Hohdatsu T, Okada S, Ishizuka Y, Yamada H, Koyama H: The prevalence of types I and II feline coronavirus infections in cats. J Vet Med Sci. 1992, 54: 557-562. 10.1292/jvms.54.557.View ArticlePubMedGoogle Scholar
- Benetka V, Kubber-Heiss A, Kolodziejek J, Nowotny N, Hofmann-Parisot M, Mostl K: Prevalence of feline coronavirus types I and II in cats with histopathologically verified feline infectious peritonitis. Vet Microbiol. 2004, 99: 31-42. 10.1016/j.vetmic.2003.07.010.View ArticlePubMedGoogle Scholar
- Kummrow M, Meli ML, Haessig M, Goenczi E, Poland A, Pedersen NC, Hofmann-Lehmann R, Lutz H: Feline coronavirus serotypes 1 and 2: seroprevalence and association with disease in Switzerland. Clin Diagn Lab Immunol. 2005, 12: 1209-1215.PubMed CentralPubMedGoogle Scholar
- Lin CN, Su BL, Wang CH, Hsieh MW, Chueh TJ, Chueh LL: Genetic diversity and correlation with feline infectious peritonitis of feline coronavirus type I and II: a 5-year study in Taiwan. Vet Microbiol. 2009, 136: 233-239. 10.1016/j.vetmic.2008.11.010.View ArticlePubMedGoogle Scholar
- Herrewegh AA, Smeenk I, Horzinek MC, Rottier PJ, de-Groot RJ: Feline coronavirus type II strains 79–1683 and 79–1146 originate from a double recombination between feline coronavirus type I and canine coronavirus. J Virol. 1998, 72: 4508-4514.PubMed CentralPubMedGoogle Scholar
- Lin CN, Chang RY, Su BL, Chueh LL: Full genome analysis of a novel type II feline coronavirus NTU156. Virus Genes. 2012, 46: 316-322.View ArticlePubMedGoogle Scholar
- McKeirnan AJ, Evermann JF, Davis EV, Ott RL: Comparative properties of feline coronaviruses in vitro. Can J Vet Res. 1987, 51: 212-216.PubMed CentralPubMedGoogle Scholar
- Pedersen NC, Evermann JF, McKeirnan AJ, Ott RL: Pathogenicity studies of feline coronavirus isolates 79–1146 and 79–1683. Am J Vet Res. 1984, 45: 2580-2585.PubMedGoogle Scholar
- Tekes G, Spies D, Bank-Wolf B, Thiel V, Thiel HJ: A reverse genetics approach to study feline infectious peritonitis. J Virol. 2012, 86: 6994-6998. 10.1128/JVI.00023-12.PubMed CentralView ArticlePubMedGoogle Scholar
- Chang HW, de-Groot RJ, Egberink HF, Rottier PJ: Feline infectious peritonitis: insights into feline coronavirus pathobiogenesis and epidemiology based on genetic analysis of the viral 3c gene. J Gen Virol. 2010, 91: 415-420. 10.1099/vir.0.016485-0.View ArticlePubMedGoogle Scholar
- Chang HW, Egberink HF, Halpin R, Spiro DJ, Rottier PJ: Spike protein fusion Peptide and feline coronavirus virulence. Emerg Infect Dis. 2012, 18: 1089-1095. 10.3201/eid1807.120143.PubMed CentralView ArticlePubMedGoogle Scholar
- Chang HW, Egberink HF, Rottier PJ: Sequence analysis of feline coronaviruses and the circulating virulent/avirulent theory. Emerg Infect Dis. 2011, 17: 744-746. 10.3201/eid1704.102027.PubMed CentralView ArticlePubMedGoogle Scholar
- Pedersen NC, Liu H, Dodd KA, Pesavento PA: Significance of coronavirus mutants in feces and diseased tissues of cats suffering from feline infectious peritonitis. Viruses. 2009, 1: 166-184. 10.3390/v1020166.PubMed CentralView ArticlePubMedGoogle Scholar
- Rusu D, Loret S, Peulen O, Mainil J, Dandrifosse G: Immunochemical, biomolecular and biochemical characterization of bovine epithelial intestinal primocultures. BMC Cell Biol. 2005, 6: 42-10.1186/1471-2121-6-42.PubMed CentralView ArticlePubMedGoogle Scholar
- Reed L, Muench H: A simple method for estimating fifty percent endpoints. Am J Hyg. 1938, 27: 493-497.Google Scholar
- Kaeffer B: Mammalian intestinal epithelial cells in primary culture: a mini-review. In Vitro Cell Dev Biol Anim. 2002, 38: 123-134. 10.1290/1071-2690(2002)038<0123:MIECIP>2.0.CO;2.View ArticlePubMedGoogle Scholar
- Baer PC, Bereiter-Hahn J: Epithelial cells in culture: injured or differentiated cells?. Cell Biol Int. in pressGoogle Scholar
- Pedersen NC, Allen CE, Lyons LA: Pathogenesis of feline enteric coronavirus infection. J Feline Med Surg. 2008, 10: 529-541. 10.1016/j.jfms.2008.02.006.View ArticlePubMedGoogle Scholar
- Herrewegh AA, Vennema H, Horzinek MC, Rottier PJ, de-Groot RJ: The molecular genetics of feline coronaviruses: comparative sequence analysis of the ORF7a/7b transcription unit of different biotypes. Virology. 1995, 212: 622-631. 10.1006/viro.1995.1520.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.